BC Partners completed the acquisition of IGS GeboJagema from Smile Invest and Rabo Private Equity.

BC Partners, a private equity investment firm specializing in buyout investments in Europe and the United States, completed the acquisition of a majority stake in IGS GeboJagema, a healthcare manufacturer in the tooling market for medical devices, from Smile Invest, a European evergreen investment firm, and Rabo Private Equity, a private equity firm investing in Benelux-based growth companies. Financial terms are not disclosed. "Partnering with BC Partners marks an exciting new chapter for IGS. Their investment is a strong recognition of the expertise, innovation, and commitment that our team has demonstrated in becoming a global leader in precision tooling for the medical industry. BC Partners brings a deep understanding of the healthcare and specialised manufacturing sectors, and their experience with businesses like Aenova, IMA, Synthon and Pharmathen makes them an ideal partner for our next phase of growth," Herman Rusch, IGS GeboJagema CEO.